Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nemaura Medical Inc
(NQ:
NMRD
)
0.1053
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nemaura Medical Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) UK licensee, MySugarWatch, Begins Direct-to-Consumer Campaign in Daily Mail
May 17, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Stocks That Hit 52-Week Lows On Friday
May 13, 2022
On Friday, 153 companies set new 52-week lows.
Via
Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
May 03, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022
April 25, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct
April 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct
April 04, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct
April 01, 2022
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
March 29, 2022
Upgrades
Via
Benzinga
Nemaura To Participate At Maxim Group Virtual Growth Conference
March 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference
March 25, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference
March 25, 2022
Via
Investor Brand Network
Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market
March 23, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
March 23, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
March 22, 2022
Via
Investor Brand Network
Nemaura Enters Commercialization Phase Of Development
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development
March 21, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues
March 18, 2022
Via
Investor Brand Network
Nemaura Medical's sugarBEAT(R) CGM Device Met With Early Success
March 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success
March 14, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success
March 11, 2022
Via
Investor Brand Network
Nemaura Medical Recognized As Innovator Of The Year
March 01, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year
March 01, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences
February 28, 2022
Via
Investor Brand Network
Nemaura Medical Producing What Was Thought To Be Implausible
February 24, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) has long...
Via
Benzinga
Nemaura Medical (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
February 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
February 23, 2022
Via
Investor Brand Network
Nemaura (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions Worldwide
February 18, 2022
Via
Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide
February 17, 2022
Via
Investor Brand Network
Nemaura Reports Financial Results, Business Updates for Q3 2022
February 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
February 15, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.